Brazil’s Butantan Institute has developed its own Covid-19 vaccine, which it plans to roll out in the coming months and offer to low income countries to help fight the pandemic.
Sao Paulo-based Butantan, which has partnered with China’s Sinovac Biotech Ltd. to produce the CoronaVac shot, will begin trials for its own vaccine -- dubbed the ButanVac -- with plans to have supplies ready by July, the institute’s director Dimas Covas said at a press conference on Friday.